EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Proton pump inhibitor prescribing patterns and utilization: A retrospective chart review analysis

Aljoharah M Algabbani, Abdulaziz S Alangari

Saudi Pharmaceutical Journal · 2023-12 · 31 (12) · 101841

DOI: 10.1016/j.jsps.2023.101841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Saudi Pharmaceutical Journal, 2023-12. Verfasst von Aljoharah M Algabbani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, College of Public Health and Health Informatics, King Saud bin Abdulaziz University for Health Sciences…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Proton pump inhibitors (PPIs) show a high level of efficacy and a high safety profile, and they have been increasingly prescribed in recent years. However, recent pharmacoepidemiological evidence has shown that PPI use has been associated with health risks and complications.

Objectives

This study aimed to assess the prescribing patterns of proton pump inhibitors and the prevalence of potential drug-drug interactions (DDIs) among patients who use PPIs.

Method

This was a retrospective analysis of electronic health records from the Ministry of National Guard Hospitals in Riyadh from January 2019 to June 2022. All adult patients who used PPIs were included to assess the prescribing patterns and drug utilization, including the number of prescriptions, duration of prescriptions, number of doses, and prescription indications. Potential DDIs were assessed based on concurrent use, which is defined as taking an interacting drug parallel to PPIs. The assessment includes complete or partial overlapping, with at least one day of overlapping.

Results

The total number of PPI prescriptions was 80,365 for a total of 9,930 patients with a mean age of 67.5. The majority of PPIs were prescribed in high doses (74%), without reporting appropriate indications (95%), and 17% were prescribed for long-term use. A total of 24,575 (33.6%) potential DDIs with PPIs were found.

Conclusion

The results showed that the majority of the PPI prescriptions were made with a high number of doses, without reporting appropriate indications, with some having potential DDIs. This might result in exposing patients to an increasing number of health risks. The findings highlight the importance of implementing a stewardship program for PPI prescription with periodic reassessments of patients' needs for these medications.

Schlagwörter

Stichwörter der Autor:innen

Drug utilizationPPIsPatient safety

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, College of Public Health and Health Informatics, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.
  • Saudi Food and Drug Authority, Riyadh, Saudi Arabia.

Zitieren

APA

Algabbani, A. M., & Alangari, A. S. (2023). Proton pump inhibitor prescribing patterns and utilization: A retrospective chart review analysis. Saudi Pharmaceutical Journal, 31(12), 101841. https://doi.org/10.1016/j.jsps.2023.101841

Vancouver

Algabbani AM, Alangari AS. Proton pump inhibitor prescribing patterns and utilization: A retrospective chart review analysis. Saudi Pharmaceutical Journal. 2023;31(12):101841. doi:10.1016/j.jsps.2023.101841

BibTeX
@article{Algabbani2023,
  author = {Algabbani, Aljoharah M and Alangari, Abdulaziz S},
  title = {Proton pump inhibitor prescribing patterns and utilization: A retrospective chart review analysis},
  journal = {Saudi Pharmaceutical Journal},
  year = {2023},
  volume = {31},
  number = {12},
  pages = {101841},
  doi = {10.1016/j.jsps.2023.101841}
}
Kostenlos starten →